FibroBiologics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2023 to Q3 2024
Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
FibroBiologics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2023 to Q3 2024.
FibroBiologics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $2.85M.
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.